Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study-Reference-Cited by-同舟云学术

Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study

Published:2018-06 Issue:6 Volume:29 Page:1431-1436
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Gramatzki D.,Roth P.,Rushing E.J.,Weller J.,Andratschke N.,Hofer S.^ORCID,Korol D.,Regli L.,Pangalu A.,Pless M.,Oberle J.,Bernays R.,Moch H.,Rohrmann S.,Weller M.

Funder

Betty and David Koetser Foundation

University Hospital Zurich

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/29/6/1431/25057125/mdy106.pdf

Reference13 articles.

1. European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas;Weller;Lancet Oncol.,2017

2. Standards of care for treatment of recurrent glioblastoma–are we there yet?;Weller;Neuro Oncol.,2013

3. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma;Friedman;J Clin Oncol.,2009

4. Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma;Kreisl;J Clin Onclol.,2009

5. Lomustine and bevacizumab in progressive glioblastoma;Wick;N Engl J Med.,2017

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical and neurologic management of brain tumor patients;Current Opinion in Neurology;2024-09-03

2. Investigating Expression Dynamics of miR-21 and miR-10b in Glioblastoma Cells In Vitro: Insights into Responses to Hypoxia and Secretion Mechanisms;International Journal of Molecular Sciences;2024-07-22

3. ID1high/activin Ahigh glioblastoma cells contribute to resistance to anti-angiogenesis therapy through malformed vasculature;Cell Death & Disease;2024-04-24

4. High costs, low quality of life, reduced survival, and room for improving treatment: an analysis of burden and unmet needs in glioma;Frontiers in Oncology;2024-03-20

5. Radio-pathomic maps of glioblastoma identify phenotypes of non-enhancing tumor infiltration associated with bevacizumab treatment response;Journal of Neuro-Oncology;2024-02-19